Burning Rock Biotech Ltd Quarterly Deferred Tax Assets, Net of Valuation Allowance in CNY from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Burning Rock Biotech Ltd quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Burning Rock Biotech Ltd Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was ¥2.78M, a 79.6% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (CNY)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 2.78M -10.9M -79.6% Dec 31, 2023 20-F 2024-04-29
Q4 2022 13.6M -15.2M -52.7% Dec 31, 2022 20-F 2024-04-29
Q4 2021 28.8M +28.8M Dec 31, 2021 20-F 2023-04-20
Q4 2020 0 Dec 31, 2020 20-F 2022-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.